StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical gross margin

Gross margin is gross profit as a percentage of revenue.

Acro Biomedical's gross margin for the twelve months ending Sep 30, 2023 was 17.8%. For fiscal 2022 it was 21.3%, against 21.7% the year before. The highest annual figure on record is 21.7% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 202221.3%−0.3
FY2021Dec 31, 202121.7%+11.7
FY2019Sep 30, 201910.0%−0.4
FY2018Sep 30, 201810.4%+0.4
FY2017Sep 30, 201710.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2022CQ4 2022Dec 31, 202217.8%−11.9
Q1 FY2022CQ1 2022Mar 31, 202225.6%+15.6
Q4 FY2021CQ4 2021Dec 31, 202125.1%+14.6
Q2 FY2021CQ2 2021Jun 30, 202116.0%+5.1
Q1 FY2021CQ1 2021Mar 31, 202129.6%+19.6
Q1 FY2019CQ4 2018Dec 31, 201810.0%+0.0
Q4 FY2018CQ3 2018Sep 30, 201810.5%–
Q3 FY2018CQ2 2018Jun 30, 201810.9%–
Q2 FY2018CQ1 2018Mar 31, 201810.0%–
Q1 FY2018CQ4 2017Dec 31, 201710.0%–

More Acro Biomedical figures

See a number that looks wrong?